Development and evaluation of intestinal targeted mucoadhesive microspheres of Bacillus coagulans

References

• Mitsuoka T. (1992). Role of intestinal flora in health with special reference to dietary control of intestinal flora. In: Hga BH, Lee YK, eds. Microbiology Applications in Food Biotechnology. London: Elsevier Science Publishers Ltd., pp. 135–148.
   Google Scholar
• Kim HS, Gilliland SE. (1983). Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans. J Dairy Sci, 66:959–966.
   PubMed Web of Science ®Google Scholar
• Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. (1999). New aspects of probiotics—a novel approach in the management of food allergy. Allergy, 54:909–915.
   PubMed Web of Science ®Google Scholar
• Orrhage K, Nord CE. (2000). Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res, 26:95–111.
   PubMedGoogle Scholar
• Sanders ME, Morelli L, Tompkins TA. (2003). Spore formers as human probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Comp Rev Food Sci Food Saf, 2:101–110.
   PubMedGoogle Scholar
• Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS. (1997). Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis, 18:833–841.
   PubMed Web of Science ®Google Scholar
• Krasaekoopt W, Bhandari B, Deeth H. (2003). Evaluation of encapsulation techniques of probiotics for yoghurt. Int Dairy J, 13:3–13.
   Web of Science ®Google Scholar
• Chandramouli V, Kailasapathy K, Peiris P, Jones M. (2004). An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions. J Microbiol Methods, 56:27–35.
   PubMed Web of Science ®Google Scholar
• Gilliand SE, Speck ML. (1977). Instability of Lactobacillus acidophilus in yogurt. J Dairy Sci, 60:1394–1398.
   Web of Science ®Google Scholar
• Lankaputhra WEV, Shah NP. (1995). Survival of Lactobacillus acidophilus and Bifidobacterium spp. in the presence of acid and bile salts. Cult Dairy Prod J, 30:2–7.
   Google Scholar
• O’Riordan K, Andrews D, Buckle K, Conway P. (2001). Evaluation of microencapsulation of a Bifidobacterium strain with starch as an approach to prolonging viability during storage. J Appl Microbiol, 91:1059–1066.
   PubMed Web of Science ®Google Scholar
• Shah NP. (2000). Probiotic bacteria: selective enumeration and survival in dairy foods. J Dairy Sci, 83:894–907.
   PubMed Web of Science ®Google Scholar
• Sultana K, Godward G, Reynolds N, Arumugaswamy R, Peiris P, Kailasapathy K. (2000). Encapsulation of probiotic bacteria with alginate-starch and evaluation of survival in simulated gastrointestinal conditions and in yoghurt. Int J Food Microbiol, 62:47–55.
   PubMed Web of Science ®Google Scholar
• Asane GS, Nirmal SA, Rasal KB, Naik AA, Mahadik MS, Rao YM. (2008). Polymers for mucoadhesive drug delivery system: a current status. Drug Dev Ind Pharm, 34:1246–1266.
   PubMed Web of Science ®Google Scholar
• Belgamwar V, Shah V, Surana SJ. (2009). Formulation and evaluation of oral mucoadhesive multiparticulate system containing metoprolol tartarate: an in vitro–ex vivo characterization. Curr Drug Deliv, 6:113–121.
   PubMedGoogle Scholar
• Chowdary KP, Rao YS. (2004). Mucoadhesive microspheres for controlled drug delivery. Biol Pharm Bull, 27:1717–1724.
   PubMed Web of Science ®Google Scholar
• Bora PS, Puri V, Bansal AK. (2009). Physicochemical properties and excipient compatibility studies of probiotic Bacillus coagulans spores. Sci Pharm, 77:625–637.
   Google Scholar
• Li CL, Martini LG, Ford JL, Roberts M. (2005). The use of hypromellose in oral drug delivery. J Pharm Pharmacol, 57:533–546.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Owen SC, eds. (2006). Handbook of Pharmaceutical Excipients, 5th ed. Britain: Great Pharmaceutical Press and Washington DC: American Pharmacists Association, pp. 346–358.
   Google Scholar
• Zhang L, Liu Y, Wu Z, Chen H. (2009). Preparation and characterization of coacervate microcapsules for the delivery of antimicrobial oyster peptides. Drug Dev Ind Pharm, 35:369–378.
   PubMed Web of Science ®Google Scholar
• United States Pharmacopoeial Convention (USPC). (2007). United States Pharmacopoeia-National Formulary (USP-NF) 2008. Rockville, MD: US Pharmacopoeial Convention, Inc., pp. 639–641, 814, 820.
   Google Scholar
• Shakoori AR, Anwar S, Khurshed N, Riaz-ul-Haq. (1999). Biocidal activity of Bacillus species for Anopheles larvae. Folia Biol (Krakow), 47:143–148.
   PubMed Web of Science ®Google Scholar
• Yassin AE, Alanazi FK, El-Badry M, Alsarra IA, Barakat NS, Alanazi FK. (2009). Preparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying technique. Drug Dev Ind Pharm, 35:297–304.
   PubMed Web of Science ®Google Scholar
• Fan Y, Shan-Guang W, Yu-Fang P, Feng-Lan S, Tao L. (2009). Preparation and characteristics of erythromycin microspheres for lung targeting. Drug Dev Ind Pharm, 35:639–645.
   PubMed Web of Science ®Google Scholar
• Nagda C, Chotai NP, Patel U, Patel S, Soni T, Patel P et al. (2009). Preparation and characterization of spray-dried mucoadhesive microspheres of aceclofenac. Drug Dev Ind Pharm, 35:1155–1166.
   PubMed Web of Science ®Google Scholar
• Lehr CM, Bowstra JA, Tukker JJ, Junginer HE. (1990). Intestinal transit of bioadhesive microspheres in an in-situ loop in the rat. J Control Release, 13:51–62.
   Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
   PubMed Web of Science ®Google Scholar
• Soni T, Chotai N. (2010). Assessment of dissolution profile of marketed aceclofenac formulations. J Young Pharm, 2:21–26.
   PubMedGoogle Scholar
• Donskey CJ, Hoyen CK, Das SM, Farmer S, Dery M, Bonomo RA. (2001). Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice. Lett Appl Microbiol, 33:84–88.
   PubMed Web of Science ®Google Scholar
• Chi N, Tang X, Xu H. (2009). Development and optimization of chemically stable lipid microspheres containing flunarizine. Drug Dev Ind Pharm, 35:738–745.
   PubMed Web of Science ®Google Scholar